BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3836295)

  • 1. Minoxidil in a once-a-day step-3 antihypertensive program.
    Oh MS; Uribarri J; Alveranga D; Bazilinski N; Lazar I; Carroll HJ
    J Clin Hypertens; 1985 Mar; 1(1):23-9. PubMed ID: 3836295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of severe hypertension with minoxidil in a once-a-day treatment regimen.
    Nicholson GD; Fraser HS; Hassell TA; Bayley A
    J Clin Hypertens; 1985 Dec; 1(4):295-303. PubMed ID: 3836299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minoxidil, nadolol, and a diuretic. Once-a-day therapy for resistant hypertension.
    Spitalewitz S; Porush JG; Reiser IW
    Arch Intern Med; 1986 May; 146(5):882-6. PubMed ID: 3963979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minoxidil in the management of intractable hypertension.
    Mackay A; Isles C; Henderson I; Fife R; Kennedy AC
    Q J Med; 1981; 50(198):175-90. PubMed ID: 7302117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-a-day triple therapy with low-dose minoxidil for moderate hypertension.
    Traub YM; Boner G; Johnsen AM; McDonald RH; Shapiro AP; Rosenfeld JB
    Isr J Med Sci; 1986 May; 22(5):360-4. PubMed ID: 3744783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the antihypertensive effect of atenolol in fixed or free combination with chlorthalidone.
    Nissinen A; Tuomilehto J
    Pharmatherapeutica; 1980; 2(7):462-8. PubMed ID: 7010382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of moderate and severe hypertension with minoxidil.
    Thien T; Huysmans FT; van Leeuwen K; Tiggeler RG; Rosier JG; Koene RA
    Neth J Med; 1979; 22(6):185-90. PubMed ID: 522930
    [No Abstract]   [Full Text] [Related]  

  • 8. Minoxidil in severe and moderately severe hypertension, in association with methyldopa and chlortalidone.
    Cotorruelo JG; Llamazares C; Flórez J
    Angiology; 1982 Nov; 33(11):710-9. PubMed ID: 7137653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-a-day therapy in patients with moderate-to-severe hypertension.
    McChesney JA
    J Natl Med Assoc; 1984 Jul; 76 Suppl(Suppl):47-53. PubMed ID: 6471122
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.
    Motolese M; Agabiti-Rosei E; Carotti A; Innocenti P; Montervino C; Solinas E; Toso M; Muiesan G
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):332-7. PubMed ID: 7409934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of hypertension with a fixed combination of bopindolol and chlorthalidone (Sandoretic)].
    Widimský J; Lánská V; Hulínský V; Balazovjech I; Havlík V; Havránek P; Kroupa E; Nikodýmová L; Pátek F; Svítil F; Svihovcová P
    Vnitr Lek; 1996 Apr; 42(4):223-8. PubMed ID: 8693706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory hypertension.
    Gillum RF
    J Natl Med Assoc; 1984 Nov; 76(11):1048. PubMed ID: 6502722
    [No Abstract]   [Full Text] [Related]  

  • 13. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.
    Leenen FH; Wilson TW; Bolli P; Larochelle P; Myers M; Handa SP; Boileau G; Tanner J
    Can J Cardiol; 1997 Oct; 13(10):914-20. PubMed ID: 9374947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fixed combination of oxprenolol slow-release and chlorthalidone once daily in treatment of mild to moderate hypertension.
    Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Toso M; Valori C; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):249-55. PubMed ID: 7309298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minoxidil in refractory hypertension: benefits, risks.
    Marquez-Julio A; From GL; Uldall PR
    Proc Eur Dial Transplant Assoc; 1977; 14():501-8. PubMed ID: 600967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine substituted for minoxidil in the treatment of refractory hypertension.
    Heagerty AM; Bing RF; Thurston H; Swales JD
    J Hum Hypertens; 1987 Sep; 1(2):83-6. PubMed ID: 2906371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid control of severe hypertension with minoxidil.
    Alpert MA; Bauer JH
    Arch Intern Med; 1982 Nov; 142(12):2099-104. PubMed ID: 6753777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial therapy of essential hypertension: diuretic or beta blocker?
    Finnerty FA
    J Fam Pract; 1980 Aug; 11(2):199-205. PubMed ID: 6106039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One year efficacy and tolerability of oxprenolol slow-release and chlorthalidone on fixed combination in mild to moderate hypertension.
    Masoni A; Tomasi AM; Pirani R; Lazzaretto R; Ambroso G
    G Ital Cardiol; 1981; 11(12):2105-9. PubMed ID: 7346306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.